Research Statement

Research Keywords

• Public health and Medicaid program policy
• Primary and secondary prevention of cardiovascular disease
• Pharmacoepidemiology
• Pharmacoeconomics
• Patient adherence and persistence with pharmacotherapeutic regimens
• Health Services Research
• Health Outcomes
• Detection and treatment of osteoporosis
• Aging

Presentations

• Acute Treatment of Migraine in Patients with Cardiovascular Disease or Risk Factors. 2010 American Association of Neuorology Annual Meeting. Toronto, Canada. Conference Paper, Refereed, Other, 2010.
• LaFleur J, Nelson R, McAdam-Marx C, Pickard S, Nebeker J. “Electronic clinical and administrative data can be used to predict patients at risk of fragility fracture” [podium presentation]. 2009 HSR&D (Health Services Research and Development) National Meeting. Baltimore, Maryland. February 2009. Conference Paper, Other, 2009.
• Predictors of an osteoporosis diagnosis in male United States veterans. 2009 Western Pharmacoeconomics Conference. Palo Alto, California. Pasadena, California. Conference Paper, Refereed, Other, 2009.
• Any-cause hospitalization outcomes associated with poor patient adherence to antihypertensives. 2nd International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia, and Diabetes Mellitus. Valencia, Spain. Conference Paper, Refereed, Presented, 2009.
• Electronic clinical and administrative data can be used to predict patients at risk of fragility fracture. 2009 HSR&D (Health Services Research and Development) National Meeting. Baltimore, Maryland. Conference Paper, Refereed, Presented, 2009.
• Gathering evidence for clinical decision support in male osteoporosis in veterans. 2009 University of Utah Center on Aging Research Retreat. Salt Lake City, Utah. Conference Paper, Refereed, Presented, 2009.
• Clinical risk factors for fracture: Applying research to knowledge-engineering for decision support. University of Utah Division of Geriatrics and Veterans Affairs Salt Lake City Geriatric Research, Education, and Clinical Center (GRECC) Geriatric Research Conference. Invited Talk/Keynote, Presented, 2009.
• A risk stratification rule for identifying males at risk of fracture based on clinical and administrative data. American Society of Bone and Mineral Research 31st Annual Meeting. Denver, Colorado. Poster, Presented, 2009.
• Acute Treatment of Migraine in Patients with Cardiovascular Disease or Risk Factors. 14th International Headache Congress. Philadelphia, PA. Poster, Presented, 2009.
• Patterns of Acute Medication Use in Individuals with Cardiovascular Disease or Risk Factors. 14th International Headache Congress. Philadelphia, PA. Poster, Presented, 2009.
• Predictors of bisphosphonate treatment in male United States veterans. Western Pharmacoeconomics Conference. Pasadena, California. Poster, Presented, 2009.
• LaFleur J, Nelson R, Pickard SG, Nebeker JR. “Recognition of male osteoporosis is low” [poster]. American Society for Bone Mineral Research 30th Annual Meeting. Montreal, Quebec, Canada. September 2008. Conference Paper, Presented, 2008.
• Nelson R, LaFleur J, McAdam-Marx C, Ward R, Brixner DI. “Patent extension policies for pediatric indications: An evaluation of the impact within one drug class in one state Medicaid Program” [poster]. AcademyHealth 25th Annual Research Meeting. Washington, DC. June 2008. Conference Paper, Presented, 2008.
• LaFleur J, Ghate SR, Sauer B. “Updating the RxRisk-V: Creating a crosswalk between VA and FirstDataBank therapeutic categories” [poster and abstract]. International Society for Pharmacoeconomics and Outcomes Research 13th Annual International Meeting. Toronto, Ontario, Canada. May 2008. Value In Health 2008:11(3): A191. Conference Paper, Presented, 2008.
• Atherton A, LaFleur J, Oderda G. “Comparison of pharmacist-mediated versus physician-directed interventions intiated by clinical pharmacists revieweing Utah Medicaid patients' medication profiles” [poster and abstract]. American College of Clinical Pharmacists 2008 Spring Practice and Research Forum. Phoenix, Arizona. April 2008. Pharmacotherapy 2008:28(4): 72e. Conference Paper, Presented, 2008.
• LaFleur J, Ghate SR, Ye X. “Estimating sociodemographic variables in a pharmacy dataset: applying data from US Census 2000” [poster and abstract]. International Society for Pharmacoeconomics and Outcomes Research 13th Annual International Meeting. Toronto, Ontario, Canada. May 2008. Value In Health 2008:11(3):A175. Conference Paper, Presented, 2008.
• Ghate SR, LaFleur J, Sauer B, Charland S. “A modified RxRisk-V comorbidity index predicts adherence with lipid lowering therapy” [poster and abstract]. International Society for Pharmacoeconomics and Outcomes Research 13th Annual International Meeting. Toronto, Ontario, Canada. May 2008. Value In Health 2008:11(3): A185. Conference Paper, Presented, 2008.
• LaFleur J, Pickard SG, Nebeker JR. “Recognition and treatment of osteoporosis is low in at least one VISN” [podium presentation]. 2008 HSR&D (Health Services Research and Development) National Meeting. Baltimore, Maryland. February 2008. Conference Paper, Presented, 2008.
• LaFleur J. “Clinical risk factors for fracture among postmenopausal patients at risk for fracture” [continuing medical education talk]. Salt Lake City Bone Club. Salt Lake City, Utah. February 2008. Invited Talk/Keynote, Presented, 2008.

Publications

• LaFleur J. Control your cholesterol: Some helpful tips. Pharmacy Times. December 2008;74(12):93-4. Published, 2008.
• LaFleur J. 2-minute consultation: Target hyperlipidemia. Pharmacy Times. September 2008;74(9):40. Published, 2008.
• LaFleur J, McAdam-Marx C, Kirkness C, Brixner DI. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature. Annals of Pharmacotherapy. 2008;42(3):375-86. Published, 2008.
• LaFleur J. Biopharmaceuticals: Definitions and terms. Pharmacy Times. August 2008;74(8 Supplement): 20. Published, 2008.
• LaFleur J, Fish L, Brixner DI. Trends in pharmaceutical expenditures: The impact on drug benefit design. American Health and Drug Benefits. 2008;1(5):29-33. Published, 2008.
• LaFleur J. Bisphosphonates' growing role in breast cancer. Pharmacy Times. June 2008;74(6):24-25. Published, 2008.